INS and Hyperinsulinemia: This may represent a compensatory mechanism to maintain quasi‐hyperinsulinemia to counterbalance the defect in β‐cell function, ~78% decline in DI, and ~46% decline in first‐phase insulin secretion in the presence of type 2 diabetes (Table 1).